Subanalyses of elderly Type 2 diabetes patients or type 2 diabetes patients with renal impairment

Trial Identifier:	D5551R00011
Sponsor:	AstraZeneca
NCTID::	NCT02917057
Start Date:	August 2015
Primary Completion Date:	August 2015
Study Completion Date:	August 2015
Condition:	Diabetes: Type 2

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
USA, MA	Boston, MA, USA, 02215

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.